FONAR (FONR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jun, 2025Executive summary
Total MRI scan volume at HMCA-managed sites rose 5% year-over-year to 53,054 for Q1 FY2025, despite a sequential decline due to hurricane-related disruptions in Florida.
Total revenues decreased 3% year-over-year to $25.0 million, with net income down 25% to $4.0 million and diluted EPS down 22% to $0.46.
Income from operations fell 30% year-over-year to $4.6 million, reflecting higher costs and lower patient fee revenue.
Working capital increased 2% to $124.7 million, and book value per share rose to $25.32 from $23.88 a year ago.
Financial highlights
Cash and cash equivalents decreased 4% to $54.2 million at September 30, 2024, from June 30, 2024.
Total assets were $212.3 million, with total liabilities at $53.5 million and stockholders' equity at $158.8 million as of September 30, 2024.
Net cash flow from operating activities was $1.7 million for Q1 FY2025, down from $2.6 million a year earlier.
Selling, general and administrative expenses increased 5% year-over-year to $5.1 million.
Outlook and guidance
Management expects the addition of high-field MRI scanners in Florida and New York to drive increased referrals and profitability.
Plans are underway to install more high-field MRIs at busy Long Island sites and to expand or acquire new centers.
Latest events from FONAR
- Independent directors secured a cash buyout at a premium, pending key stockholder approvals.FONR
Proxy Filing26 Feb 2026 - Six-month net income fell 16%, but quarterly net income rose 15%; merger at $19/share signed.FONR
Q2 202617 Feb 2026 - Definitive merger agreement signed for $19.00/share; quarterly net income up 15% year-over-year.FONR
Proxy Filing17 Feb 2026 - Management-led buyout at $19/share offers 31.5% premium, pending shareholder approval.FONR
Proxy Filing30 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditors amid continued growth and strong liquidity.FONR
Proxy Filing2 Dec 2025 - Revenue up 4% to $26M, but net income down 33% as costs rise and uncertainty persists.FONR
Q1 202614 Nov 2025 - Revenue up 1%, net income down 24%, with record scan volumes and expansion plans.FONR
Q4 202525 Sep 2025 - Net income rose 16% on record scan volumes and continued expansion of MRI centers.FONR
Q4 202413 Jun 2025 - Q3 net income up 24%, but nine-month profit fell as costs and scan volumes rose.FONR
Q3 20256 Jun 2025